Human Genome Sciences hgsi.com


Human Genome Sciences is a development stage company that was formed to develop and commercialize therapeutically enhanced proprietary biopharmaceuticals with the aim of offering significant reductions in dosage, injection frequency, side effects, and overall cost of treatment. In July 2012, Human Genome Sciences was acquired by GlaxoSmithKline. The valuation of Human Genome Sciences was $3.6 billion.

Human Genome Sciences is a development stage company that was formed to develop and commercialize therapeutically enhanced proprietary biopharmaceuticals with the aim of offering significant reductions in dosage, injection frequency, side effects, an...Show all

Company (Acquired)

Phone:

Fax:

14200 Shady Grove Road

Rockville, 20850
Maryland, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Human Genome Sciences $0M Jul 17, 2012
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Human Genome Sciences Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
HealthCare VenturesVenture CapitalCambridge, Massachusetts, United StatesOther Investors
Rho VenturesVenture CapitalNew York, New York, United StatesOther Investors
See all 2 investors

Competitors

Company Status Description Investors
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Vascular endothelial growth factor 2 May 15, 2014 Aug 02, 2016 Patent
Albumin fusion proteins Aug 05, 2015 Mar 29, 2016 Patent
Albumin fusion proteins Feb 02, 2015 Dec 29, 2015 Patent
Antibodies that immunospecifically bind to b lymphocyte stimulator protein Jan 23, 2012 Nov 17, 2015 Patent
Methods and compositions for use in treatment of patients with autoantibody positive disease Jun 06, 2008 Oct 27, 2015 Patent
See all 113 patents